Literature DB >> 18273500

Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma.

M Raica1, L Mogoantă, Anca Maria Cîmpean, Aurora Alexa, S Ioanovici, Cl Mărgăritescu, Daniela Lazăr, D Izvernariu.   

Abstract

BACKGROUND: Gastric cancer still represents a difficult problem in the field of oncology, in terms of morbidity and mortality. The local progression and systemic spread is significantly influenced by tumor angiogenesis and lymphangiogenesis. In spite of many studies on the topic, data about the significance of growth factors in gastric cancer is controversial. AIM: to investigate the immunohistochemical expression of VEGF and to evaluate the relationships with the tumors stage and grade.
MATERIAL AND METHODS: The immunohistochemical expression of VEGF was investigated on 80 patients with intestinal type gastric carcinoma. Specimens were fixed in buffer formalin, embedded in paraffin, and sections were stained with Hematoxylin-Eosin and immunohistochemistry was performed for VEGF (clone VG-1). Evaluation was performed using the VEGF score, based on the intensity of reaction and percent of positive cells.
RESULTS: The reaction for VEGF was positive in 52 from 80 cases (70%). The final product of reaction was found in the cytoplasm of tumor cells, with granular pattern. Positive reaction was also found in eight from 28 cases with associated intestinal metaplasia, and in six from nine cases with gastric dysplasia. In the adjacent apparently normal mucosa, the reaction was positive in hyperplastic gastric pits and parietal cells. A strong correlation was found between VEGF expression and lymph node status and grade of the primary, but not with the stage of the tumor.
CONCLUSIONS: The investigation of the immunohistochemical expression of VEGF in the intestinal type of gastric carcinoma showed positive reaction in 70% of the cases. It was demonstrated the expression of VEGF in intestinal metaplasia and gastric dysplasia, which could signify an early angiogenic switch during tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18273500

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  5 in total

1.  Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.

Authors:  Shing Hwa Liu; Chin Chang Shen; Yu Chiao Yi; Jaw Ji Tsai; Chih Chien Wang; Ju Ting Chueh; Keh Liang Lin; Tso Ching Lee; Hung Chuan Pan; Meei Ling Sheu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats.

Authors:  Xiao-Yan Wang; Lou-Lei Wang; Xuan Zheng; Li-Na Meng; Bin Lyu; Hai-Feng Jin
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

3.  Plasma VEGF and Leptin Values in Patients With Gastric Intestinal Metaplasia and Metabolic Syndrome.

Authors:  George Pappas-Gogos; Kostas Tepelenis; Anna Goussia; Constantinos Tellis; Fotis Fousekis; Georgios K Glantzounis; Konstantinos Vlachos
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

4.  Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer.

Authors:  Mladen Pavlovic; Nevena Gajovic; Milena Jurisevic; Slobodanka Mitrovic; Gordana Radosavljevic; Jelena Pantic; Nebojsa Arsenijevic; Ivan Jovanovic
Journal:  Gastroenterol Res Pract       Date:  2018-10-04       Impact factor: 2.260

5.  Association between VEGF-634G>C Gene Polymorphism with Gastric Premalignant Lesions and Serum VEGF Levels in Helicobacter pylori Gastritis Patients.

Authors:  Gontar Alamsyah Siregar; Ida Parwati; Tri Hanggono Achmad; Yoni Fuadah Syukriani
Journal:  Open Access Maced J Med Sci       Date:  2018-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.